Αρχειοθήκη ιστολογίου

Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174

Τετάρτη 23 Μαρτίου 2022

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence radioactive iodine 5h Tracking Uptake and Metabolism of Xenometallomycins Using a Multi-Isotope Tagging Strategy radioactive iodine 5h A Study to Assess the Effect of Size & Site of Tympanic Membrane Perforation on Hearing Loss Otolaryngology Indian 8h Response to “Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries” by Kao liebertpub1 12h Sex Differences in Differentiated Thyroid Cancer liebertpub1 12h Unique Molecular Signatures Are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer liebertpub1 12h Severe Resistance to Thyroid Hormone Beta in a Patient with Athyreosis liebertpub1 12h Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes liebertpub1 12h For more inform


Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence
radioactive iodine
5h
Tracking Uptake and Metabolism of Xenometallomycins Using a Multi-Isotope Tagging Strategy
radioactive iodine
5h
A Study to Assess the Effect of Size & Site of Tympanic Membrane Perforation on Hearing Loss
Otolaryngology Indian
8h
Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao
liebertpub1
12h
Sex Differences in Differentiated Thyroid Cancer
liebertpub1
12h
Unique Molecular Signatures Are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer
liebertpub1
12h
Severe Resistance to Thyroid Hormone Beta in a Patient with Athyreosis
liebertpub1
12h
Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes
liebertpub1
12h
For more information and a current list of upcoming thyroid-related meetings, visit www.thyroid.org/professionals/meetings
liebertpub1
12h
Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018
liebertpub1
12h
Functional Characterization of the Novel and Specific Thyroid Hormone Transporter SLC17A4
liebertpub1
12h
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial
liebertpub1
12h
Comparison and Validation of Acoustic Voice Quality Index Version 2 and Version 3 among South Indian Population
Voice
14h
Where do we come from? Where are we? Where are we going? : President's speech at the 92nd Annual Meeting of the German Society of Otorhinolaryngology, Head and Neck Surgery on the occasion of its centennial. German version
hno
15h
Eustachian tube dysfunction after cleft palate surgery : Use of the latest diagnostics
hno
15h
Survey of Pediatric Otolaryngology Frenotomy Practice Patterns
The Laryngoscope
16h
Breast reconstruction during the COVID-19 pandemic: Single institution experience from the pandemic's epicenter in the United States
Journal of plastic, reconstructive & aesthetic surgery : JPRAS
17h
"Pandemic puppies" - The UK animal bite pandemic
Journal of plastic, reconstructive & aesthetic surgery : JPRAS
17h
The impact of parity in primary breast augmentation: A clinical and cost-effective case control study
Journal of plastic, reconstructive & aesthetic surgery : JPRAS
17h
Monomeric C-reactive protein level is associated with osteoarthritis
Experimental and therapeutic medicine
17h
MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1
Experimental and therapeutic medicine
17h
miR-150-5p inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by targeting VDR
Experimental and therapeutic medicine
17h
Expression of TMED3 is independently associated with colorectal cancer prognosis
Experimental and therapeutic medicine
17h
Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia-induced pancreatitis <em>in vitro</em>
Experimental and therapeutic medicine
17h
Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma
Experimental and therapeutic medicine
17h
Effects and early diagnostic value of lncRNA H19 on sepsis-induced acute lung injury
Experimental and therapeutic medicine
17h
Adrenocortical carcinoma: Pediatric aspects (Review)
Experimental and therapeutic medicine
17h
Circular RNA hsa_circ_0011946 promotes the malignant process of salivary adenoid cystic carcinoma by downregulating miR-1205 expression
Experimental and therapeutic medicine
17h
MicroRNA-200a-3p and GATA6 are abnormally expressed in patients with non-small cell lung cancer and exhibit high clinical diagnostic efficacy
Experimental and therapeutic medicine
17h
Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression
Experimental and therapeutic medicine
17h
Nephroprotective effect of magnesium isoglycyrrhizinate against arsenic trioxide-induced acute kidney damage in mice
Experimental and therapeutic medicine
17h
Anagliptin promotes apoptosis in mouse colon carcinoma cells via MCT-4/lactate-mediated intracellular acidosis
Experimental and therapeutic medicine
17h
pH regulates the lumen diameter of tissue-engineered capillaries
Experimental and therapeutic medicine
17h
Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review)
Experimental and therapeutic medicine
17h
An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report
Experimental and therapeutic medicine
17h
S100A9 blockade improves the functional recovery after spinal cord injury via mediating neutrophil infiltration
Experimental and therapeutic medicine
17h
A propósito de un caso: procedimiento EXIT (<em>Extrauterine Intrapartum Treatment</em>) en gestación con teratoma cervical
Acta Otorrinolaringológica Española
17h
Language lateralization and outcome in perinatal stroke patients with different vascular types
Brain and Language
17h
Neuroradiological Basis of COVID‐19 Olfactory Dysfunction: A Systematic Review and Meta‐Analysis
The Laryngoscope
18h
Endoscopic Image Luminance Enhancement Based on the Inverse Square Law for Illuminance and Retinex
The International Journal of Medical Robotics and Computer Assisted Surgery
18h
Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution
Head & Neck
20h
Radiologic–pathologic correlation of major versus minor extranodal extension in oral cavity cancer
Head & Neck


Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution
20h
by
David R. Gilley, Andrew D. Clark, Maggie E. Wieser, Craig A. Bollig, Laura M. Dooley, Gregory B. Biedermann
via
Head & Neck
Abstract
Background
Gabapentin has been shown to reduce opioid use in head and neck cancer patients. Here, we examine the efficacy of prophylactic gabapentin at reducing opioid use in these patients at our institution.

Methods
A retrospective study of patients receiving radiation was performed, using patients from our previous study as controls. Risk factors for opioid use at 3 and 6 months were determined using univariate and multivariate analyses.

Results
In total, 53/185 patients were treated with gabapentin, 39.6% of which took opioids at 3 months vs. 58.3% in the non-gabapentin cohort (p = 0.021). Gabapentin was independently associated with less opioid use on multivariate analysis at 3 months (OR 0.47, 95% CI 0.24–0.9). Gastrostomy tube dependence and pretreatment opioid use were associated with chronic opioid use despite gabapentin.

Conclusions
Gabapentin is effective at expediting opioid tapering in head and neck cancer patients who are not gastrostomy tube dependent or taking opioids pretreatment.

Add tags
   Create note
Radiologic–pathologic correlation of major versus minor extranodal extension in oral cavity cancer
20h
by
Michael A. Blasco, Christopher W. Noel, Tra Truong, Shao Hui Huang, David P. Goldstein, Jonathan C. Irish, Ralph Gilbert, Ali Hosni, Andrew Hope, Brian O'Sullivan, John Waldron, Bayardo Perez‐Ordonez, Ilan Weinreb, Stephen M. Smith, Eric Bartlett, Eugene Yu, John R. Almeida
via
Head & Neck
Abstract
Background
To evaluate the diagnostic performance of radiologic extranodal extension (rENE) in predicting major (>2 mm) and minor (≤2 mm) pathologic ENE (pENE).

Methods
All oral cavity squamous cell carcinoma patients who underwent neck dissection with pathological nodal disease (pN+) between 2010 and 2015 were reviewed. Preoperative computed tomography and/or magnetic resonance imaging were reviewed by two head and neck neuroradiologists.

Results
Three hundred and thirty-four patients were included. The sensitivity and specificity of rENE were 37% [95% CI 29–44] and 98% [95% CI 96–100], respectively. Sensitivity for pENE improved in the subset of patients with major ENE (48% [95% CI 38–57]). The presence of rENE was associated with inferior 3-year overall survival: 26% [95% CI 17–41] versus 60% [95% CI 54–67].

Conclusions
This large cohort study demonstrates high specificity, but low sensitivity for preoperative imaging in the detection of pENE in OCSCC. Patients with rENE demonstrated poor OS. pENE in the absence of rENE is still an adverse risk factor.

Add tags
   Create note

#
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Telephone consultation 11855 int 1193,

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου